Background-Sudden death due to relatively innocent chest-wall impact has been described in young individuals (commotio cordis). In our previously reported swine model of commotio cordis, ventricular fibrillation (with T-wave strikes) and ST-segment elevation (with QRS strikes) were produced by 30-mph baseball impacts to the precordium. Because activation of the K
S
udden death may occur in young sports participants when a baseball or other projectile strikes the victim over the precordium, even in the absence of structural damage to the chest wall and heart. This phenomenon is termed commotio cordis, and it predominantly affects individuals aged 5 to 18 years without preexisting heart disease. 1,2 A 1996 United States Consumer Product Safety Commission report found 38 deaths from baseball blows to the chest between 1973 and 1995. 3 In addition, commotio cordis has been reported in ice hockey, lacrosse, and softball and as the consequence of fistfights 1,4 -7 ; indeed, it may be more common than initially believed. 8 Currently, the Commotio Cordis Registry (Minneapolis, Minn) has recorded 70 victims of commotio cordis. 2 In our previously described model of commotio cordis, 9 we observed ventricular fibrillation with 30-mph impacts occurring 15 to 30 ms before the peak of the T-wave. In addition, ST-segment elevation was produced by impacts on the QRS and ST segments. However, the cellular mechanisms responsible for these striking electrophysiological consequences of blunt chest impact are unknown. Because many of the profound electrophysiological consequences observed in our experimental model of commotio cordis are similar to those of myocardial ischemia, we hypothesized that the cellular mechanisms for ST-segment elevation and ventricular fibrillation in these 2 circumstances may also be comparable.
The cardiac K ϩ ATP channel is normally inactive, 10 as it is inhibited by physiological concentrations of ATP. The opening of the channel is associated with a reduction in the cellular ATP/ADP ratio, such as occurs in myocardial ischemia. 11, 12 It is thought that activation of this channel is responsible for the ST-segment elevation observed in myocardial ischemia. [11] [12] [13] [14] [15] Furthermore, activation of this channel increases the likelihood of ventricular fibrillation occurring during myocardial ischemia. 13,16 -19 Glibenclamide is a sulfonylurea that primar-ily acts by blocking the K ϩ ATP channel. 20 -22 Preventing K ϩ ATP channel activation with glibenclamide decreases the magnitude of ST-segment elevation 14, 15 and the incidence of ventricular fibrillation in myocardial ischemia. 13,16 -19 To test the hypothesis that abrupt mechanical activation of the K ϩ ATP channel may be a mechanism by which virtually instantaneous sudden death results from chest-wall impact, glibenclamide (a selective blocker of the K ϩ ATP channel) was administered to animals subsequently subjected to lowenergy chest-wall impact.
Methods
Juvenile domesticated swine, 4 to 8 weeks old and weighing 8 to 12 kg, were used in this study. The research protocol was approved by the Animal Research Committee of the New England Medical Center in conformity with the regulations of the Association for Assessment and Accreditation of Laboratory Animal Care. Animals were anesthetized with ketamine and isoflurane and intubated; intravenous catheters were placed; and an infusion of 5% dextrose was begun.
A 5% solution of glibenclamide was constituted by dissolving 5 mg of glibenclamide in 1 mL of 1 mol/L NaOH, 1 mL of 70% ethanol, and 0.7 mL of dimethyl sulfoxide in 100 mL of normal saline. 17 After infusing the active agent, animals were placed prone in a sling to approximate physiological blood flow and cardiac hemodynamics ( Figure 1 ). Chest-wall impact was produced by a spherical wooden object (150 g), identical in size and weight to a baseball, propelled at 30 mph. The impact object was directed, using echocardiographic guidance, to strike the animal perpendicular to the chest wall directly overlying the heart.
In the first series of experiments, 0.5 mg/kg glibenclamide was administered intravenously to 6 animals, after which 1 to 3 chest impacts on the QRS segment of the cardiac cycle were delivered. The results of these experiments were compared with those previously performed without the prior administration of glibenclamide, in which 10 impacts were delivered to the QRS in 9 animals. 9 The maximum ST-segment elevation in both experimental groups was measured in the first 2 beats after chest impact (0.08 s after the J-point).
In the second phase of the study, either the active agent (glibenclamide) or the control vehicle was administered to a total of 20 animals. Each animal received 1 to 3 chest impacts timed from Ϫ10 ms to Ϫ40 ms before the peak of the T-wave, a period vulnerable to the induction of ventricular fibrillation. 9 The peak of the T-wave was determined from a monophasic T-wave on either lead 1 or 2 on surface ECG. If ventricular fibrillation occurred, no further impacts were given. All laboratory personnel were blinded to the identity of the infused solution (active or control) except the laboratory technician responsible for administering it.
Differences between groups of animals were analyzed with the unpaired Student's t test for continuous variables (ie, magnitude of ST elevation) and Fisher's Exact Test for nominal variables (eg, incidence of ventricular fibrillation). PՅ0.05 was considered significant.
Results

QRS Impacts
The 6 glibenclamide-treated animals were subjected to 14 QRS impacts. At baseline (before each impact), ST segments were isoelectric ( Figure 2 ). The mean post-impact STsegment elevation was 0.16Ϯ0.10 mV (Table 1 ). In the 9 previously studied animals that were not given glibenclamide and received 10 QRS impacts, ST segment elevation was 0.35Ϯ0.20 mV, more than 2-fold greater than the animals who were given glibenclamide (Pϭ0.004). In both groups of animals, the maximum ST-segment elevation was present on the first beat after impact and decreased to baseline over the following 30 to 60 s, without development of Q-waves or T-wave abnormalities ( Figure 2 ). In animals subjected to QRS impact, there were no differences between glibenclamide-treated and control animals with regard to the occurrence of transient heart block (3 of 14 [21%] versus 4 of 10 [40%]) or left bundle branch pattern (14 of 14 versus 9 of 10). Ventricular fibrillation did not occur with QRS impacts (Table 1) .
T-Wave Impact
Ten animals received 0.5 mg/kg glibenclamide, and a total of 27 chest-wall blows were delivered on the upslope of the T-wave; ventricular fibrillation occurred with only 1 of the 27 impacts (4%; ie, in 10% of the animals) ( Table 2 and Figure  3) . Ventricular tachycardia or transient polymorphic ventricular tachycardia did not occur, and premature ventricular contractions were induced by the chest blow in all animals. In contrast, in the 10 animals who received the control solution, 18 chest blows delivered at the upslope of the T-wave produced 6 episodes of ventricular fibrillation (33%; ie, in 60% of the animals; Pϭ0.01) and 2 episodes of nonsustained polymorphic ventricular tachycardia. In those impacts that did not result in ventricular fibrillation, no significant differences existed between glibenclamide-treated and control animals with respect to ST-segment elevation (0. 
Discussion
Our swine model of chest impact-related sudden death shares many similarities with the human phenomenon of commotio cordis, including the importance of impact location and velocity, difficulty with resuscitation, and absence of significant thoracic or cardiac injury. 9, 23 In the present and previous studies, we showed that the initiation of ventricular fibrillation (and, thus, sudden death) with low-energy chest-wall blows is critically dependent on the timing of the blow to a vulnerable portion of the cardiac cycle. 9 Ventricular fibrillation occurred instantaneously with 30-mph impacts just before the T-wave peak, and it was not preceded by intervening ventricular tachycardia, conduction abnormalities, or ischemic ST changes. Our obser- Complete heart block 4 (40%) 3 (21%) 0.39 *Control animals were from a prior and previously reported experiment. 9 vations imply that the ventricular fibrillation produced by lowenergy chest blows is not secondary to coronary spasm, myocardial ischemia, hemorrhage, heart block, or ventricular tachycardia, but rather is a primarily electrical phenomenon.
Nevertheless, the cellular mechanisms responsible for this electrical event are unknown. In experimental models of myocardial ischemia, STsegment elevation and ventricular arrhythmias are due, in part, to selective activation of the K ϩ ATP channel. [11] [12] [13] [14] [15] [16] [17] [18] [19] Blocking this channel with glibenclamide reduces these electrophysiologic effects of ischemia. [11] [12] [13] [14] [15] [16] [17] [18] [19] 24, 25 Because the STsegment elevation and ventricular fibrillation seen in our experimental model of commotio cordis are similar to those reported in myocardial ischemia, we hypothesized that these entities may share the same or similar cellular mechanisms. Therefore, to test the hypothesis that activation of the K ϩ ATP channel was involved in the profound electrophysiological consequences of modest chest-wall blows (including sudden cardiac death), we designed a double-blind study in which a selective blocker of the K ϩ ATP channel (glibenclamide) or a placebo was administered to swine before delivering a chest blow. Glibenclamide was chosen because its ability to block the K ϩ ATP channel has been well established. 20, 21 Indeed, in our present experiment with low-energy chest-wall blows, the incidence of ventricular fibrillation was significantly reduced from 33% of impacts (60% of animals) in controls to only 4% of impacts (10% of animals) in glibenclamide-treated animals. These results suggest that it is the immediate mechanical activation of the K ϩ ATP channel by low-energy chest-wall impact that is, in part, responsible for the ventricular fibrillation seen in our experimental model and, by inference, in sudden death on the playing field in young athletes.
Prominent ST-segment elevation was also produced in our model of commotio cordis, 9 and it has also been reported in a few survivors of commotio cordis. 5, 26, 27 We found that ST-segment elevation was most pronounced with QRS impacts, but it was observed with chest impacts throughout the cardiac cycle. 9 ST-segment elevations were most marked on the beat following the impact; then, they decayed and normalized over the next 30 to 60 s. In the present study, glibenclamide attenuated the ST-segment elevation observed with QRS impacts, substantiating our hypothesis that the K ϩ ATP channel is activated by mechanical trauma to the chest wall in commotio cordis. It is presently unresolved as to why ST-segment elevation was more pronounced with QRS strikes compared with T-wave strikes. 9 The present experiment provides convincing evidence that chest-wall impacts occurring on both T-wave and QRS segments result in activation of the K ϩ ATP channel (Figure 4 ). Whether this activation leads to ventricular fibrillation or to ST-segment elevation depends on the timing of the impact. As seen in our previous experiment, 9 only impacts that occurred during the vulnerable time period of repolarization caused ventricular fibrillation. That a vulnerable period for the initiation of ventricular fibrillation exists suggests that a second trigger or condition is necessary (in addition to K ϩ ATP channel activation) for ventricular fibrillation to result from a mechanical force such as a low-energy chest-wall blow. At the current time, this additional trigger or condition is unknown, but it is likely related to the dispersion of repolarization that is present during the vulnerable period of the cardiac cycle. We previously observed marked hemorrhage in the AV bundle and bundle branches in 1 of 2 animals with transient heart block induced by chest-wall impact, suggesting that direct trauma to the conduction system caused the manifestations of heart block. 9 In support of this theory, in the present study, we found no difference in the incidence of heart block or left bundle branch block in the glibenclamide-treated or control animals. Thus, these observations, taken together, suggest that the left bundle branch block and transient heart block that was observed in our experiments is primarily a consequence of direct mechanical trauma rather than activation of the K ϩ ATP channel. In conclusion, in this experimental model of commotio cordis, glibenclamide significantly decreased the incidence of ventricular fibrillation and the magnitude of ST segment elevation. Therefore, direct mechanical activation of the K ϩ ATP channel seems to be an important cellular mechanism by which ventricular fibrillation occurs in commotio cordis. Magnitude of ST-segment elevation and incidence of ventricular fibrillation induced by 30-mph chest-wall impacts by spherical object (size and weight of regulation baseball) in our experimental model of commotio cordis. Significant differences between control and glibenclamide-treated animals were observed in magnitude of ST-segment elevation with QRS strikes and in incidence of ventricular fibrillation with T-wave strikes.
